MCP-4 and Eotaxin-3 Are Novel Biomarkers for Chronic Obstructive Pulmonary Disease

Table 2

Characteristics of stable COPD and AECOPD patients.

	Stable COPD (n = 12)	AECOPD (n = 35)	value
Age	73.01 ± 2.82	74.16 ± 1.66	0.09
Gender (male/female)	9/3	25/10	0.81
Body mass index (kg/m^2)	21.13 ± 0.71	21.45 ± 0.42	0.07
Years of smoking	26.21 ± 4.33	27.66 ± 1.42	0.09
Quitting time (year)	6.28 ± 1.49	6.68 ± 0.82	0.25
WBC (×10^9/L)	16.98 ± 3.01	18.95 ± 3.14	0.06
RBC (×10^12/L)	4.52 ± 0.21	4.65 ± 0.30	0.17
Lymphocytes (%)	15.42 ± 3.46	14.45 ± 2.98	0.36
Neutrophils (%)	84.56 ± 8.32	87.87 ± 8.56	0.25
Eosinophils (%)	2.86 ± 0.29	3.09 ± 0.38	0.06
CRP (mg/L)	7.34 ± 3.29	15.58 ± 4.56	<0.05
IL-6 (pg/mL)	4.63 ± 2.02	6.05 ± 1.68	<0.05
ESR (mg/L)	27.01 ± 2.93	29.88 ± 6.22	0.13